p63 expression in benign and malignant breast lesions

Area of Science:

• Oncology
• Cell Biology
• Histopathology

Background:

• The p63 gene encodes multiple protein isoforms with diverse functions.
• p63 is known to be expressed in the myoepithelial layer of mammary epithelium.
• Myoepithelial cells play crucial roles in maintaining tissue structure and function.

Purpose of the Study:

• To investigate the immunohistochemical expression of p63 in benign and malignant breast lesions.
• To compare p63 expression with established myoepithelial cell markers.
• To evaluate p63 as a diagnostic marker for myoepithelial cells in breast pathology.

Main Methods:

• Immunohistochemical analysis of p63 expression using anti-p63 antibodies.
• Comparison with antibodies for alpha-smooth muscle actin, S-100 protein, and cytokeratin 14.
• Evaluation of 140 benign and 126 malignant breast lesions.

Main Results:

• p63 was consistently expressed in the myoepithelial layer of benign breast lesions.
• A reduced p63 signal was observed in the myoepithelial cells of in situ carcinomas.
• Invasive breast carcinomas lacked peripheral p63 staining.
• p63 expression was noted in a subset of epithelial cells in papillary lesions, similar to S-100 staining.

Conclusions:

• p63 is a sensitive and specific marker for myoepithelial cells in breast tissue.
• p63 can aid in the identification of myoepithelial cells in difficult breast lesions.
• Papillary neoplasms may exhibit myoepithelial differentiation markers.